Efficacy and Safety of Neoadjuvant Therapies for High-Risk and Locally Advanced Prostate Cancer in Older Adults: A Systematic Review and Network Meta-Analysis - Top-Institutions - MDSpire

Efficacy and Safety of Neoadjuvant Therapies for High-Risk and Locally Advanced Prostate Cancer in Older Adults: A Systematic Review and Network Meta-Analysis

  • By

  • Yuan, Wenling

  • Wang, Yu

  • Liu, Qi

  • Tian, Fangyuan

  • Guo, Mengran

  • May 8, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLA

    Los Angeles, California

    Key Differentiators

    • Urology

  • #2

    MARCAP Consortium
    MARCAP Consortium

    N/A, N/A

    Key Differentiators

    • Urology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    Commack, New York

    Key Differentiators

    • Urology

  • #4

    Weill Cornell Medicine
    Weill Cornell Medicine

    New York, New York

    Key Differentiators

    • Urology

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Urology

Original Source(s)

Efficacy and Safety of Neoadjuvant Therapies for High-Risk and Locally Advanced Prostate Cancer in Older Adults: A Systematic Review and Network Meta-Analysis

  • by Yuan, Wenling , Wang, Yu , Liu, Qi , Tian, Fangyuan , Guo, Mengran

  • May 8, 2026

Related Content

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer